CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14
Titel:
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14
Auteur:
Patterson, Bruce K. Seethamraju, Harish Dhody, Kush Corley, Michael J. Kazempour, Kazem Lalezari, Jay Pang, Alina P.S. Sugai, Christopher Mahyari, Eisa Francisco, Edgar B. Pise, Amruta Rodrigues, Hallison Wu, Helen L. Webb, Gabriela M. Park, Byung S. Kelly, Scott Pourhassan, Nader Lelic, Alina Kdouh, Lama Herrera, Monica Hall, Eric Bimber, Benjamin N. Plassmeyer, Matthew Gupta, Raavi Alpan, Oral O’Halloran, Jane A. Mudd, Philip A. Akalin, Enver Ndhlovu, Lishomwa C. Sacha, Jonah B.